Unveiling 6 Analyst Insights On Treace Medical Concepts
Unveiling 6 Analyst Insights On Treace Medical Concepts
公布分析师对Treace医疗概念的6点见解
Analysts' ratings for Treace Medical Concepts (NASDAQ:TMCI) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
6位分析师提供的分析师对Treace Medical Concepts（纳斯达克股票代码：TMCI）在上个季度的评级从看涨到看跌不等。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $8.17, a high estimate of $16.00, and a low estimate of $5.50. A negative shift in sentiment is evident as analysts have decreased the average price target by 48.39%.
分析师分析的12个月目标股价提供了见解，平均目标价为8.17美元，最高估计为16.00美元，低估值为5.50美元。随着分析师将平均目标股价下调了48.39％，情绪的负面转变显而易见。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
A comprehensive examination of how financial experts perceive Treace Medical...
对金融专家如何看待T...
登录免费看全文
登录/注册